Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Neurology|November 14, 2024
Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic IndicationsCarson M Quinn, Prashanth Rajarajan, Alexander J Gill, et al.Cancer Research Communications|April 19, 2026
Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung CancerMichael Conroy, Jaime Wehr, Vivian V Altiery De Jesus, et al.Cancer Treatment and Research Communications|July 23, 2025
Peripheral blood cells as prognostic markers in patients with advanced non-small cell lung cancer treated with cemiplimab as monotherapy or in combination with chemotherapyRolando J Acosta, Debra A G McIntyre, Joseph C Murray, et al.The Oncologist|August 16, 2022
Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer ImmunotherapyMelinda L Hsu, Joseph C Murray, Kevin J Psoter, et al.Journal of Neuro-Oncology|July 16, 2025
Distinct size and spatial distribution patterns of ALK-inhibitor-naïve versus ALK-inhibitor exposed ALK-positive NSCLC brain metastasesTia Cheunkarndee, Zsombor Ritter, Max Saint-Germain, et al.Cancer Research Communications|February 26, 2024
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLCMari Nakazawa, Guilherme Harada, Paola Ghanem, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2026
plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid TumorsJenna V Canzoniero, Daniel Rabizadeh, Ilias Ziakas, et al.Journal for Immunotherapy of Cancer|June 10, 2022
Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapyMichael Hwang, Jenna Vanliere Canzoniero, Samuel Rosner, et al.Biorxiv : the Preprint Server for Biology|July 10, 2023
Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancerJoseph C Murray, Lavanya Sivapalan, Karlijn Hummelink, et al.Journal for Immunotherapy of Cancer|September 15, 2020
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancerJoshua E Reuss, Valsamo Anagnostou, Tricia R Cottrell, et al.Pageof 4